These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3942846)

  • 21. Lymphocytapheresis.
    Wright DG; Karsh J; Fauci AS; Klippel JH; Deisseroth AB; Decker JL
    Prog Clin Biol Res; 1981; 58():217-24. PubMed ID: 7267670
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and immunological effects of leukapheresis therapy using cotton-wool filter for patients with rheumatoid arthritis].
    Takeda M
    Ryumachi; 1996 Jun; 36(3):493-502. PubMed ID: 8779786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
    Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
    J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoplasmapheresis in rheumatoid arthritis.
    Rosenberg SA
    N Engl J Med; 1982 Nov; 307(20):1271. PubMed ID: 6752709
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of lymphoplasmapheresis on clinical indices and T cell subsets in rheumatoid arthritis. A double-blind controlled study.
    Verdickt W; Dequeker J; Ceuppens JL; Stevens E; Gautama K; Vermylen C
    Arthritis Rheum; 1983 Dec; 26(12):1419-26. PubMed ID: 6360178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis.
    Ueki Y; Yamasaki S; Kanamoto Y; Kawazu T; Yano M; Matsumoto K; Miyake S; Tominaga Y; Iwamoto U; Suemitsu J; Matsuno Y; Sizume Y; Takenaka Y; Eguchi K
    Rheumatology (Oxford); 2000 Feb; 39(2):165-71. PubMed ID: 10725066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunocorrective therapy of rheumatoid arthritis by means of lymphocytoplasmopheresis].
    Miterev IuG; Nasonova VA; Dubrovina NA; Khotinian RI; Speranskiĭ AI
    Sov Med; 1982; (5):70-5. PubMed ID: 6981213
    [No Abstract]   [Full Text] [Related]  

  • 28. Extracorporeal granulocytapheresis for cancer and rheumatoid arthritis.
    Yonekawa M; Kawamura A; Komai T; Agishi T; Adachi M
    Transfus Sci; 1996 Sep; 17(3):463-72. PubMed ID: 10163555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mud treatment of patients with rheumatoid arthritis with an immunologic deficiency].
    Gorchakova GA; Pavlova ES; Ruchkina AS; Skridonenko AD
    Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (5):32-5. PubMed ID: 2603406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma exchange for rheumatoid arthritis.
    Seror R; Pagnoux C; Guillevin L
    Transfus Apher Sci; 2007 Apr; 36(2):195-9. PubMed ID: 17499763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-inducer lymphocytes, leukapheresis and the pathogenesis of rheumatoid arthritis.
    Wilder RL; Decker JL
    Clin Exp Rheumatol; 1983; 1(2):89-91. PubMed ID: 6241855
    [No Abstract]   [Full Text] [Related]  

  • 32. The current status of therapeutic apheresis in the management of rheumatoid arthritis.
    Wallace DJ; Goldfinger D; Klinenberg JR
    Prog Clin Biol Res; 1982; 106():27-32. PubMed ID: 6757943
    [No Abstract]   [Full Text] [Related]  

  • 33. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients.
    Lundberg MS; Cannon GW; Ward JR
    Arthritis Rheum; 1988 Jul; 31(7):909-13. PubMed ID: 3134898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depletion lymphocytapheresis in chronic lymphocytic leukemias: criteria for predicting which patients will respond to treatment.
    Rossi PL; Alfano G; D'Onofrio G; Menichella G; Mango G
    Int J Artif Organs; 1986 Jan; 9(1):59-62. PubMed ID: 3957456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocytapheresis (LCAP) for the treatment of rheumatoid arthritis on a maintenance hemodialysis patient.
    Ohsawa I; Ohi H; Maruyama T; Hamada H; Tomino Y
    Clin Nephrol; 2007 Aug; 68(2):121-4. PubMed ID: 17722713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of multiple sclerosis with lymphocytapheresis using a leukocyte adsorption column].
    Sato T; Imamura N; Nozaki K; Ishigaki Y
    Nihon Rinsho; 1994 Nov; 52(11):3032-7. PubMed ID: 7996706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case report of leukocytapheresis for refractory leg ulcers complicated with rheumatoid arthritis.
    Itoh Y; Takeshita Y; Ozawa Y; Tohma S; Umemura S
    Ther Apher Dial; 2006 Oct; 10(5):419-24. PubMed ID: 17096696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drainage of thoracic lymph duct in the treatment of patients with rheumatoid arthritis].
    Siniachenko VV; Siniachenko OV; Kvasha VI; Diadyk AI; Kharaberiush VA
    Ter Arkh; 1982; 54(9):96-9. PubMed ID: 7179164
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of filtration leukocytapheresis(LCAP) in rheumatoid arthritis(RA)].
    Ueki Y; Takashima H; Matsumoto K; Miyake S; Hidaka T; Suzuki K; Eguchi K
    Nihon Rinsho; 2002 Dec; 60(12):2296-303. PubMed ID: 12510353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lymphocytopheresis and plasmapheresis in rheumatoid arthritis].
    Dubrovina NA; Kalinin NN; Khotinian RI; Molchanova NP; Petrov MM
    Revmatologiia (Mosk); 1984; (3):9-12. PubMed ID: 6390635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.